Variant report
Variant | esv3382981 |
---|---|
Chromosome Location | chr3:85162733-85165838 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552355968 | chr3:85162807-85162808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570967475 | chr3:85162813-85162814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538307927 | chr3:85162814-85162815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs5850668 | chr3:85162819-85162820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550220248 | chr3:85162821-85162822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs397876850 | chr3:85162827-85162828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199563832 | chr3:85162836-85162837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs148721496 | chr3:85162837-85162838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568390261 | chr3:85162843-85162844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573796347 | chr3:85162848-85162849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs397877590 | chr3:85162849-85162850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555678015 | chr3:85162850-85162851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554207936 | chr3:85162865-85162866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150506065 | chr3:85162912-85162913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34992129 | chr3:85163010-85163011 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs557888145 | chr3:85163013-85163014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs139479014 | chr3:85163042-85163043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183003204 | chr3:85163055-85163056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562590657 | chr3:85163062-85163063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6773806 | chr3:85163167-85163168 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs541808533 | chr3:85163180-85163181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188140111 | chr3:85163187-85163188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192940060 | chr3:85163199-85163200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs527542019 | chr3:85163256-85163257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144515278 | chr3:85163270-85163271 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116634385 | chr3:85163275-85163276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531512847 | chr3:85163336-85163337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs35737808 | chr3:85163377-85163378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550331940 | chr3:85163425-85163426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114661487 | chr3:85163457-85163458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201696191 | chr3:85163510-85163511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs578082009 | chr3:85163546-85163547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535525300 | chr3:85163548-85163549 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147839134 | chr3:85163575-85163576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542140607 | chr3:85163586-85163587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75301349 | chr3:85163593-85163594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112555172 | chr3:85163660-85163661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs73843296 | chr3:85163711-85163712 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs558009616 | chr3:85163722-85163723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569952520 | chr3:85163765-85163766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141439741 | chr3:85163768-85163769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183810542 | chr3:85163782-85163783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145204210 | chr3:85163866-85163867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533402790 | chr3:85163884-85163885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368277898 | chr3:85163886-85163887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145007577 | chr3:85163983-85163984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553694546 | chr3:85163987-85163988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541956177 | chr3:85163989-85163990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs375627698 | chr3:85163990-85163991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572393384 | chr3:85164015-85164016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Autism | 22102821 | CNVD |
Prostate cancer | 21307934 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:85153000-85168200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
2 | chr3:85163200-85163600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr3:85164800-85165200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |